Cholesterol lowering effects of mono-lactose-appended β-cyclodextrin in Niemann–Pick type C disease-like HepG2 cells

Scholarly Works

• Wu, J.; Li, J.; Shao, W.; Hu, Y.; Chen, H.; Chen, Y.; Chen, Y.; Liu, Q.; Ao, M. Cyclodextrins as therapeutic drugs for treating lipid metabolism disorders. Obesity reviews : an official journal of the International Association for the Study of Obesity 2024, 25, e13687. doi:10.1111/obr.13687
• Ohashi, M.; Tamura, A.; Yui, N. Exploring Receptor Binding Affinities and Hepatic Cell Association of N-Acetyl-d-Galactosamine-Modified β-Cyclodextrin-Based Polyrotaxanes for Liver-Targeted Therapies. Biomacromolecules 2023, 24, 2327–2341. doi:10.1021/acs.biomac.3c00194
• Ishitsuka, Y.; Irie, T.; Matsuo, M. Cyclodextrins applied to the treatment of lysosomal storage disorders. Advanced drug delivery reviews 2022, 191, 114617. doi:10.1016/j.addr.2022.114617
• Nishida, T.; Yokoyama, R.; Kubohira, Y.; Maeda, Y.; Takeo, T.; Nakagata, N.; Takagi, H.; Ishikura, K.; Yanagihara, K.; Misumi, S.; Kishimoto, N.; Ishitsuka, Y.; Kondo, Y.; Irie, T.; Soga, M.; Era, T.; Onodera, R.; Higashi, T.; Motoyama, K. Lactose-Appended Hydroxypropyl-β-Cyclodextrin Lowers Cholesterol Accumulation and Alleviates Motor Dysfunction in Niemann-Pick Type C Disease Model Mice. ACS applied bio materials 2022, 5, 2377–2388. doi:10.1021/acsabm.2c00233
• Zakany, F.; Kovacs, T.; Szente, L.; Varga, Z. Cyclodextrins as promising therapeutics against cholesterol overload. Cholesterol; Elsevier, 2022; pp 927–967. doi:10.1016/b978-0-323-85857-1.00028-6
• Ishikura, K.; Yanagihara, K.; Takagi, H. Synthesis of branched cyclodextrins using activated carbon as a catalyst. Journal of Inclusion Phenomena and Macrocyclic Chemistry 2021, 101, 91–99. doi:10.1007/s10847-021-01089-z
• Matencio, A.; Hoti, G.; Monfared, Y. K.; Rezayat, A.; Pedrazzo, A. R.; Caldera, F.; Trotta, F. Cyclodextrin Monomers and Polymers for Drug Activity Enhancement. Polymers 2021, 13, 1684–1701. doi:10.3390/polym13111684
• Harvey, D. ANALYSIS OF CARBOHYDRATES AND GLYCOCONJUGATES BY MATRIX-ASSISTED LASER DESORPTION/IONIZATION MASS SPECTROMETRY: AN UPDATE FOR 2015-2016. Mass spectrometry reviews 2021, 40, 408–565. doi:10.1002/mas.21651
• Matencio, A.; Caldera, F.; Cecone, C.; López-Nicolás, J. M.; Trotta, F. Cyclic Oligosaccharides as Active Drugs, an Updated Review. Pharmaceuticals (Basel, Switzerland) 2020, 13, 281. doi:10.3390/ph13100281
• Yokoyama, R.; Taharabaru, T.; Nishida, T.; Ohno, Y.; Maeda, Y.; Sato, M.; Ishikura, K.; Yanagihara, K.; Takagi, H.; Nakamura, T.; Ito, S.; Ohtsuki, S.; Arima, H.; Onodera, R.; Higashi, T.; Motoyama, K. Lactose-appended β-cyclodextrin as an effective nanocarrier for brain delivery. Journal of controlled release : official journal of the Controlled Release Society 2020, 328, 722–735. doi:10.1016/j.jconrel.2020.09.043
• Matencio, A.; Navarro-Orcajada, S.; González-Ramón, A.; García-Carmona, F.; López-Nicolás, J. M. Recent advances in the treatment of Niemann pick disease type C: A mini-review. International journal of pharmaceutics 2020, 584, 119440. doi:10.1016/j.ijpharm.2020.119440
• Zagami, R.; Romeo, A.; Mazzaglia, A.
• Maeda, Y.; Motoyama, K.; Nishiyama, R.; Higashi, T.; Onodera, R.; Nakamura, H.; Takeo, T.; Nakagata, N.; Yamada, Y.; Ishitsuka, Y.; Kondo, Y.; Irie, T.; Era, T.; Arima, H. In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease. Nanomaterials (Basel, Switzerland) 2019, 9, 802. doi:10.3390/nano9050802
• Higashi, T. Cyclodextrin-Based Molecular Accessories for Drug Discovery and Drug Delivery. Chemical & pharmaceutical bulletin 2019, 67, 289–298. doi:10.1248/cpb.c18-00735
• Crini, G.; Fourmentin, S.; Fenyvesi, É.; Torri, G.; Fourmentin, M.; Morin-Crini, N. Cyclodextrins, from molecules to applications. Environmental Chemistry Letters 2018, 16, 1361–1375. doi:10.1007/s10311-018-0763-2
• Crini, G.; Fourmentin, S.; Fenyvesi, É.; Torri, G.; Fourmentin, M.; Morin-Crini, N. Fundamentals and Applications of Cyclodextrins. Environmental Chemistry for a Sustainable World; Springer International Publishing, 2018; pp 1–55. doi:10.1007/978-3-319-76159-6_1
• Higashi, T.; Iohara, D.; Motoyama, K.; Arima, H. Supramolecular Pharmaceutical Sciences: A Novel Concept Combining Pharmaceutical Sciences and Supramolecular Chemistry with a Focus on Cyclodextrin-Based Supermolecules. Chemical & pharmaceutical bulletin 2018, 66, 207–216. doi:10.1248/cpb.c17-00765
• Tamura, A.; Ohashi, M.; Nishida, K.; Yui, N. Acid-Induced Intracellular Dissociation of β-Cyclodextrin-Threaded Polyrotaxanes Directed toward Attenuating Phototoxicity of Bisretinoids through Promoting Excretion. Molecular pharmaceutics 2017, 14, 4714–4724. doi:10.1021/acs.molpharmaceut.7b00859
• Motoyama, K.; Nishiyama, R.; Maeda, Y.; Higashi, T.; Ishitsuka, Y.; Kondo, Y.; Irie, T.; Era, T.; Arima, H. Synthesis of multi-lactose-appended β-cyclodextrin and its cholesterol-lowering effects in Niemann-Pick type C disease-like HepG2 cells. Beilstein journal of organic chemistry 2017, 13, 10–18. doi:10.3762/bjoc.13.2
• Arima, H.; Motoyama, K.; Higashi, T. Potential Use of Cyclodextrins as Drug Carriers and Active Pharmaceutical Ingredients. Chemical & pharmaceutical bulletin 2017, 65, 341–348. doi:10.1248/cpb.c16-00779

Explore citations to this article at